Sanjivani Paranteral P/B Ratio
Sanjivani Paranteral P/B ratio. Sanjivani Paranteral (SANJIVIN) P/B ratio is 4.2 (High), book value per share ₹42.50 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Sanjivani Paranteral share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SANJIVIN P/B Ratio — Valuation Insights & Book Value Analysis
Sanjivani Paranteral price-to-book ratio interpretation, valuation status and historical context — current P/B 4.2 (High). View SANJIVIN price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 4.2, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 54.2% below historical average
- Trading at premium to sector average PB of 0.01
Sanjivani Paranteral P/B Ratio Historical Trend
SANJIVIN annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse SANJIVIN promoter holding to track promoter, FII and institutional holdings.
SANJIVIN Historical P/B Ratio — Book Value Per Share & Year-End Price
Sanjivani Paranteral annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 3.9 | ₹42.5 | ₹165.95 | ₹51 | High |
| 2025 | 6.95 | ₹33.33 | ₹231.55 | ₹40 | High |
| 2024 | 16.65 | ₹23.33 | ₹388.45 | ₹28 | High |
SANJIVIN vs Healthcare Peers — P/B Ratio Comparison
Sanjivani Paranteral P/B 4.2 vs Healthcare average 0.01, median 0.61 — range -6.55–1.07.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |